Cholangiocarcinoma
- PMID: 39212921
- DOI: 10.1007/978-3-031-61238-1_9
Cholangiocarcinoma
Abstract
Cholangiocarcinoma (CC) is a heterogeneous group of malignancies that originates at any point along the biliary tree. CC is an uncommon malignancy as it represents approximately 3% of all gastrointestinal malignancies, though its global incidence is rising. CC can often be asymptomatic in its early stages and as a result, it is frequently diagnosed in later stages, leading to challenges in clinical management.
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
-
- Lendvai G, Szekerczés T, Illyés I et al (2020) Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis. Pathol Oncol Res 26(1):3–15. https://doi.org/10.1007/s12253-018-0491-8 - DOI - PubMed
-
- El-Diwany R, Pawlik TM, Ejaz A (2019) Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am 28(4):587–599. https://doi.org/10.1016/j.soc.2019.06.002 - DOI - PubMed
-
- Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31(1):12–17. https://doi.org/10.1002/hep.510310104 - DOI - PubMed
-
- Bagante F, Weiss M, Alexandrescu S et al (2018) Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma. HPB 20(12):1189–1197. https://doi.org/10.1016/j.hpb.2018.05.017 - DOI - PubMed
-
- DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762. https://doi.org/10.1097/01.sla.0000251366.62632.d3 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
